Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1Hematologic Neoplasms 1

Interventions

rozanolixizumab 6ravulizumab 5zilucoplan 4telitacicept 3fludarabine 3Cyclophosphamide 3inebilizumab 2talquetamab 1remibrutinib 1iptacopan 1efgartigimod alfa 1Therapeutics 1Prednisone 1Prednisolone 1Plasma Exchange 1Immunoglobulins, Intravenous 1HBM9161 1Cladribine 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myasthenia Gravis × Immunoglobulins, Intravenous × 90 days × Clear all
NCT07532707 2026-04-16

Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.

Damascus University

Phase NA Completed
50 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡